Cargando…
Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). T...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410685/ https://www.ncbi.nlm.nih.gov/pubmed/36042653 http://dx.doi.org/10.1097/MD.0000000000029973 |
_version_ | 1784775152339255296 |
---|---|
author | Bilik, Mehmet Zihni Oylumlu, Muhammed Oylumlu, Mustafa Acun, Baris Arik, Baran Arslan, Bayram Acet, Halit Polat, Nihat Akil, Mehmet Ata |
author_facet | Bilik, Mehmet Zihni Oylumlu, Muhammed Oylumlu, Mustafa Acun, Baris Arik, Baran Arslan, Bayram Acet, Halit Polat, Nihat Akil, Mehmet Ata |
author_sort | Bilik, Mehmet Zihni |
collection | PubMed |
description | Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). The study is a single-center, retrospective Cross-sectional study. The study group consisted of 73 patients with PAH and the control group 77 participants without cardiac pathology as determined by echocardiography. On admission, blood sampling to calculate MHR, LMR, NLR, and detailed clinical data were obtained. According to the Pearson test, systolic pulmonary artery pressure (PAP) value Higher MHR, NLR and lower LMR that indicates an enhanced inflammation were significantly increased in patients with PAH when compared with controls. Compared to many other inflammatory markers, these markers are widely available. positively correlated with the MHR and NLR (r:.35, P < .001 and r:.33, P < .001, respectively), but negatively correlated with LMR (r: −.26, P = .001). After multivariate logistic regression analysis, MHR, LMR, and NLR remained as significant predictors of PAH (OR: 2.651, 95% CI: 1.227–5.755, P = .007; OR: 0.647, 95% CI:0.450–0.931, P = .005; OR: 1.350, 95% CI: 1.054–1.650 P = .030, respectively). |
format | Online Article Text |
id | pubmed-9410685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94106852022-08-26 Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio Bilik, Mehmet Zihni Oylumlu, Muhammed Oylumlu, Mustafa Acun, Baris Arik, Baran Arslan, Bayram Acet, Halit Polat, Nihat Akil, Mehmet Ata Medicine (Baltimore) Research Article Monocyte to HDL cholesterol ratio (MHR), lymphocyte to monocyte ratio (LMR), and neutrophil to lymphocyte ratio (NLR) have been proposed as novel systemic inflammatory markers. The aim of this study was to explore the association between MHR, LMR and NLR with pulmonary arterial hypertension (PAH). The study is a single-center, retrospective Cross-sectional study. The study group consisted of 73 patients with PAH and the control group 77 participants without cardiac pathology as determined by echocardiography. On admission, blood sampling to calculate MHR, LMR, NLR, and detailed clinical data were obtained. According to the Pearson test, systolic pulmonary artery pressure (PAP) value Higher MHR, NLR and lower LMR that indicates an enhanced inflammation were significantly increased in patients with PAH when compared with controls. Compared to many other inflammatory markers, these markers are widely available. positively correlated with the MHR and NLR (r:.35, P < .001 and r:.33, P < .001, respectively), but negatively correlated with LMR (r: −.26, P = .001). After multivariate logistic regression analysis, MHR, LMR, and NLR remained as significant predictors of PAH (OR: 2.651, 95% CI: 1.227–5.755, P = .007; OR: 0.647, 95% CI:0.450–0.931, P = .005; OR: 1.350, 95% CI: 1.054–1.650 P = .030, respectively). Lippincott Williams & Wilkins 2022-08-26 /pmc/articles/PMC9410685/ /pubmed/36042653 http://dx.doi.org/10.1097/MD.0000000000029973 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Research Article Bilik, Mehmet Zihni Oylumlu, Muhammed Oylumlu, Mustafa Acun, Baris Arik, Baran Arslan, Bayram Acet, Halit Polat, Nihat Akil, Mehmet Ata Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title | Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title_full | Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title_fullStr | Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title_full_unstemmed | Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title_short | Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio |
title_sort | novel predictor of pulmonary arterial hypertension: monocyte to hdl cholesterol ratio |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410685/ https://www.ncbi.nlm.nih.gov/pubmed/36042653 http://dx.doi.org/10.1097/MD.0000000000029973 |
work_keys_str_mv | AT bilikmehmetzihni novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT oylumlumuhammed novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT oylumlumustafa novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT acunbaris novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT arikbaran novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT arslanbayram novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT acethalit novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT polatnihat novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio AT akilmehmetata novelpredictorofpulmonaryarterialhypertensionmonocytetohdlcholesterolratio |